Tag: IBC

Articles

• Foods to eat and avoid for inflammatory breast cancer (IBC)
• Inflammatory breast cancer characteristics

News

10/15/23

High-fat diet promotes inflammatory breast cancer (IBC) growth in mice

05/27/20

Genistein promotes proliferation and metastasis in IBC animal model

08/20/16

Virus related to mouse mammary tumor virus linked to breast cancer

04/07/14

Dietary mushroom intake linked to lowered risk of breast cancer

09/16/11

Reishi mushroom inhibits IBC growth, proliferation, and invasion

06/24/11

Multifocal breast cancer has worse prognosis than single tumors

10/07/10

Three cases of IBC in one office suggest environmental causes

Studies

• Characterization of mammographic markers of inflammatory breast cancer (IBC) Cite
  Barkana BD, Ahmad B, Essodegui F, Lembarki G, Pfeiffer R, Soliman AS, et al. Characterization of mammographic markers of inflammatory breast cancer (IBC). Physica Medica. Elsevier BV; 2025; 129:104870 10.1016/j.ejmp.2024.104870
• Immediate Breast Reconstruction for Inflammatory Breast Carcinoma: A Scoping Review Cite
  Davé N, Hajj JP, Ahmed S, Hulsman L, Singh NP, Fisher CS, et al. Immediate Breast Reconstruction for Inflammatory Breast Carcinoma: A Scoping Review. Journal of Surgical Oncology. Wiley; 2024; 10.1002/jso.27959
• Abstract C037: Inflammatory breast cancer by metastatic status: Racial and ethnic and socioeconomic disparities in receipt of treatment Cite
  Freeman JQ, Hara JH, Omoleye OJ. Abstract C037: Inflammatory breast cancer by metastatic status: Racial and ethnic and socioeconomic disparities in receipt of treatment. Cancer Epidemiology, Biomarkers & Prevention. American Association for Cancer Research (AACR); 2024; 33:C037-C037 10.1158/1538-7755.disp24-c037
• Rates of Pathologic Complete Response and Overall Survival in Patients with Inflammatory Breast Cancer: A National Cancer Database Study Cite
  Parrish KM, Thomas SM, Cartwright SB, van den Bruele AB, Zasloff R, DiLalla GA, et al. Rates of Pathologic Complete Response and Overall Survival in Patients with Inflammatory Breast Cancer: A National Cancer Database Study. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2024; 10.1245/s10434-024-16026-w
• Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities Cite
  Glencer AC, Wanis KN, Brown S, Lucci A, Sun SX, Adesoye T, et al. Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2024; 10.1245/s10434-024-15713-y
• Abstract PS18-07: Trends in Guideline Concordant Care for Inflammatory Breast Cancer: An analysis of the National Cancer Database Cite
  Diskin B, Tadros A, Sevilimedu V, Xu A, Vingan P, Nelson J, et al. Abstract PS18-07: Trends in Guideline Concordant Care for Inflammatory Breast Cancer: An analysis of the National Cancer Database. Cancer Research. American Association for Cancer Research (AACR); 2024; 84:PS18-07-PS18-07 10.1158/1538-7445.sabcs23-ps18-07
• Mutational landscape of inflammatory breast cancer Cite
  Bertucci F, Lerebours F, Ceccarelli M, Guille A, Syed N, Finetti P, et al. Mutational landscape of inflammatory breast cancer. Journal of Translational Medicine. Springer Science and Business Media LLC; 2024; 22 10.1186/s12967-024-05198-4
• Abstract 3171: The effect of estrogen and phytoestrogens in Inflammatory breast cancer Cite
  Peterson-Peguero EA, Rodriguez-Martir K, Ganshert M, Negron-Figueroa D, Colon-Ortiz AN. Abstract 3171: The effect of estrogen and phytoestrogens in Inflammatory breast cancer. Cancer Research. American Association for Cancer Research (AACR); 2024; 84:3171-3171 10.1158/1538-7445.am2024-3171
• Inflammatory breast cancer: challenges in diagnosis, management and disease recurrence. Cite
  Johnpulle M, Miah C, Yip C. Inflammatory breast cancer: challenges in diagnosis, management and disease recurrence.. European Journal of Surgical Oncology. Elsevier BV; 2024; 50:107504 10.1016/j.ejso.2023.107504
• Abstract B048: Disparities in treatment course and outcomes in females diagnosed with non-metastatic inflammatory breast cancer Cite
  Lung K, Sheng Y, George B, Willis A, Lazar M. Abstract B048: Disparities in treatment course and outcomes in females diagnosed with non-metastatic inflammatory breast cancer. Cancer Epidemiology, Biomarkers & Prevention. American Association for Cancer Research (AACR); 2023; 32:B048-B048 10.1158/1538-7755.disp23-b048
• Systematic Review and Meta-Analysis of Treatment Effects on Survival in Patients with Inflammatory Breast Cancer Cite
  Bahrami P, Moayeri H, Moradi G, Nouri E, Moradi Y. Systematic Review and Meta-Analysis of Treatment Effects on Survival in Patients with Inflammatory Breast Cancer. Asian Pacific Journal of Cancer Prevention. EpiSmart Science Vector Ltd; 2023; 24:3335-3343 10.31557/apjcp.2023.24.10.3335
• High-fat diet, but not duration of lactation, increases mammary gland lymphatic vessel function and subsequent growth of inflammatory breast cancer cells Cite
  Balema W, Morton J, Larson RA, Li L, Velasquez FC, Fowlkes NW, et al. High-fat diet, but not duration of lactation, increases mammary gland lymphatic vessel function and subsequent growth of inflammatory breast cancer cells. Journal of Mammary Gland Biology and Neoplasia. Springer Science and Business Media LLC; 2023; 28 10.1007/s10911-023-09548-8
• Outcomes of Breast-Conserving Therapy in Patients With Inflammatory Breast Cancer: A Meta-Analysis Cite
  Lai H, Loh E, Su C, Chiang M, Tam K. Outcomes of Breast-Conserving Therapy in Patients With Inflammatory Breast Cancer: A Meta-Analysis. Journal of Surgical Research. Elsevier BV; 2024; 293:458-467 10.1016/j.jss.2023.08.047
• Racial and Survival Disparities in Inflammatory Breast Cancer (IBC) and non-IBC: A Population-Based Study Focused on Native Hawaiians and Other Pacific Islanders Cite
  Yoshikawa G, Miyazaki K, Acoba J, Fujii T. Racial and Survival Disparities in Inflammatory Breast Cancer (IBC) and non-IBC: A Population-Based Study Focused on Native Hawaiians and Other Pacific Islanders. Research Square Platform LLC; 2023; 10.21203/rs.3.rs-3143571/v1
• Low Rates of Local-Regional Recurrence Among Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy Cite
  Adesoye T, Everidge S, Chen J, Sun SX, Teshome M, Valero V, et al. Low Rates of Local-Regional Recurrence Among Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2023; 10.1245/s10434-023-13906-5
• Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer Cite
  Carbajal-Ochoa WH, Johnson D, Alvarez A, Bernal AM, Anampa JD. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-07018-7
• The immunogram of inflammatory breast cancer Cite
  Valenza C, Trapani D, Fusco N, Wang X, Cristofanilli M, Ueno NT, et al. The immunogram of inflammatory breast cancer. Cancer Treatment Reviews. Elsevier BV; 2023;:102598 10.1016/j.ctrv.2023.102598
• Risk-dependent conditional survival analysis and annual hazard rate of inflammatory breast cancer Cite
  Meng X, Chang X, Qin P, Li Y, Guo Y. Risk-dependent conditional survival analysis and annual hazard rate of inflammatory breast cancer. European Journal of Surgical Oncology. Elsevier BV; 2023; 10.1016/j.ejso.2023.06.009
• Tailoring Treatment for Patients with Inflammatory Breast Cancer Cite
  Newman AB, Lynce F. Tailoring Treatment for Patients with Inflammatory Breast Cancer. Current Treatment Options in Oncology. Springer Science and Business Media LLC; 2023; 10.1007/s11864-023-01077-0
• Trends, survival outcomes, and predictors of nonadherence to mastectomy guidelines for nonmetastatic inflammatory breast cancer Cite
  Lehrberg A, Sebai M, Finn D, Lee D, Karabon P, Kiran S, et al. Trends, survival outcomes, and predictors of nonadherence to mastectomy guidelines for nonmetastatic inflammatory breast cancer. The Breast Journal. Hindawi Limited; 2021; 27:753-760 10.1111/tbj.14283
• Aspirin Use Is Associated With Improved Outcomes in Inflammatory Breast Cancer Patients Cite
  Johns C, Yen A, Rahimi A, Liu Y, Leitch AM, Spangler A, et al. Aspirin Use Is Associated With Improved Outcomes in Inflammatory Breast Cancer Patients. Journal of Breast Cancer. XMLink; 2023; 26 10.4048/jbc.2023.26.e3
• Complete response in the axilla and the non-triple negative subtype are favourable prognostic factors for survival outcomes in inflammatory breast cancer Cite
  Kuhar CG, Borštnar S, Gazić B, Matos E. Complete response in the axilla and the non-triple negative subtype are favourable prognostic factors for survival outcomes in inflammatory breast cancer. The Breast. Elsevier BV; 2023; 10.1016/j.breast.2023.01.011
• Inflammatory breast cancer and the importance of skin punch biopsy Cite
  Valente SA, ElSherif A, Tran J, Tu C, Kruse M. Inflammatory breast cancer and the importance of skin punch biopsy. The American Journal of Surgery. Elsevier BV; 2022; 10.1016/j.amjsurg.2022.11.017
• Inflammatory Breast Cancer: Is There a Role for Deescalation of Surgery? Cite
  Nakhlis F. Inflammatory Breast Cancer: Is There a Role for Deescalation of Surgery?. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2022; 10.1245/s10434-022-12138-3
• Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy Cite
  Hieken TJ, Boughey JC, Degnim AC, Glazebrook KN, Hoskin TL. Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2022; 10.1245/s10434-022-12037-7
• Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast Cancer Cite
  Chen JC, Li Y, Fisher JL, Bhattacharyya O, Tsung A, Bazan JG, et al. Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2022; 10.1245/s10434-022-11975-6
• Anti‐cancer Effects of Coumestrol in Triple‐Negative Inflammatory Breast Cancer 3D Models: Opportunities for In Vivo Studies Cite
  Colon‐Ortiz AN, Rodriguez‐Martir K, Negron‐Figueroa D, Peterson‐Peguero EA. Anti‐cancer Effects of Coumestrol in Triple‐Negative Inflammatory Breast Cancer 3D Models: Opportunities for In Vivo Studies. The FASEB Journal. Wiley; 2022; 36 10.1096/fasebj.2022.36.s1.r4682
• Molecular Mechanism by which Coumestrol Exerts its Anticancer Activity in Triple‐Negative Inflammatory Breast Cancer Cite
  Rodríguez‐Mártir KM, Colón‐Ortiz AN, Fuxa‐Rey V, Negrón‐Figueroa D, Morales‐Rivera CS, Carrasquillo‐Dones EA, et al. Molecular Mechanism by which Coumestrol Exerts its Anticancer Activity in Triple‐Negative Inflammatory Breast Cancer. The FASEB Journal. Wiley; 2022; 36 10.1096/fasebj.2022.36.s1.r4147
• 248P Axillary nodal involvement (ANI) predictive model by primary histopathological features in invasive breast cancer (IBC): A real-world analysis of 1,400 cases Cite
  Cutuli B, Charles C. 248P Axillary nodal involvement (ANI) predictive model by primary histopathological features in invasive breast cancer (IBC): A real-world analysis of 1,400 cases. Annals of Oncology. Elsevier BV; 2022; 33:S236 10.1016/j.annonc.2022.03.270
• Proton therapy for the treatment of inflammatory breast cancer Cite
  Fattahi S, Mullikin TC, Aziz KA, Afzal A, Smith NL, Francis LN, et al. Proton therapy for the treatment of inflammatory breast cancer. Radiotherapy and Oncology. Elsevier BV; 2022; 10.1016/j.radonc.2022.04.008
• HSR22-143: Outcome Differences Amongst Stage-Matched Inflammatory vs Non-Inflammatory Breast Cancer Patients Cite
  Grimm M, Johnson K, Schnell P, Pariser A, Gatti-Mays M, VanDeusen J, et al. HSR22-143: Outcome Differences Amongst Stage-Matched Inflammatory vs Non-Inflammatory Breast Cancer Patients. Journal of the National Comprehensive Cancer Network. Harborside Press, LLC; 2022; 20:HSR22-143 10.6004/jnccn.2021.7279
• Abstract P1-24-05: Breast conserving surgery for non-metastatic inflammatory breast cancer: A National Cancer Database (NCDB) study Cite
  Angarita FA, Edge SB, Attwood K, Takabe K, Young J. Abstract P1-24-05: Breast conserving surgery for non-metastatic inflammatory breast cancer: A National Cancer Database (NCDB) study. Cancer Research. American Association for Cancer Research (AACR); 2022; 82:P1-24-05-P1-24-05 10.1158/1538-7445.sabcs21-p1-24-05
• Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory Breast Cancer Treated with Trimodality Therapy Cite
  Song Z, Li C, Zhou D, Liu J, Qian X, Zhang J. Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory Breast Cancer Treated with Trimodality Therapy. Clinical Breast Cancer. Elsevier BV; 2022; 10.1016/j.clbc.2022.02.001
• Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research Cite
  Jagsi R, Mason G, Overmoyer BA, Woodward WA, Badve S, Schneider RJ, et al. Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 10.1007/s10549-021-06434-x
• Breast Conservation Surgery versus Modified Radical Mastectomy in the Management of Non Metastatic Inflammatory Breast Cancer Cite
  Elshinawi ME, Osman AGE, Abdelmoaty KF, Anber WAA. Breast Conservation Surgery versus Modified Radical Mastectomy in the Management of Non Metastatic Inflammatory Breast Cancer. QJM: An International Journal of Medicine. Oxford University Press (OUP); 2021; 114 10.1093/qjmed/hcab097.059
• Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis Cite
  Jiao D, Zhang J, Zhu J, Guo X, Yang Y, Xiao H, et al. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis. BMC Cancer. Springer Science and Business Media LLC; 2021; 21 10.1186/s12885-021-07855-z
• Trends, survival outcomes, and predictors of nonadherence to mastectomy guidelines for nonmetastatic inflammatory breast cancer Cite
  Lehrberg A, Sebai M, Finn D, Lee D, Karabon P, Kiran S, et al. Trends, survival outcomes, and predictors of nonadherence to mastectomy guidelines for nonmetastatic inflammatory breast cancer. The Breast Journal. Wiley; 2021; 10.1111/tbj.14283
• Current Surgical Management of Inflammatory Breast Cancer Cite
  Adesoye T, Lucci A. Current Surgical Management of Inflammatory Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 10.1245/s10434-021-10522-z
• Inflammatory breast cancer: early recognition and diagnosis is critical Cite
  Hester RH, Hortobagyi GN, Lim B. Inflammatory breast cancer: early recognition and diagnosis is critical. American Journal of Obstetrics and Gynecology. Elsevier BV; 2021; 10.1016/j.ajog.2021.04.217
• Inflammatory Breast Cancer at the Extremes of Age Cite
  Adesoye T, Babayemi O, Postlewait LM, DeSnyder SM, Sun SX, Woodward WA, et al. Inflammatory Breast Cancer at the Extremes of Age. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 10.1245/s10434-021-10453-9
• Immediate Breast Reconstruction for Inflammatory Breast Cancer: Trends in Use and Clinical Outcomes 2004–2016 Cite
  Hoffman DI, Santos PMG, Goldbach M, Keele LJ, Taunk NK, Bogen HS, et al. Immediate Breast Reconstruction for Inflammatory Breast Cancer: Trends in Use and Clinical Outcomes 2004–2016. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 10.1245/s10434-021-10404-4
• Inhibitory Effects of Coumestrol in Triple‐Negative Inflammatory Breast Cancer Cite
  Rodriguez‐Martir K, Colon A, Peterson E. Inhibitory Effects of Coumestrol in Triple‐Negative Inflammatory Breast Cancer. The FASEB Journal. Wiley; 2021; 35 10.1096/fasebj.2021.35.s1.01858
• Identification of a Positive Association between Mammary Adipose Cholesterol Content and Indicators of Breast Cancer Aggressiveness in a French Population Cite
  Goupille C, Ouldamer L, Pinault M, Guimares C, Arbion F, Jourdan ML, et al. Identification of a Positive Association between Mammary Adipose Cholesterol Content and Indicators of Breast Cancer Aggressiveness in a French Population. The Journal of Nutrition. Oxford University Press (OUP); 2021; 10.1093/jn/nxaa432
• The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer Cite
  Partain N, Postlewait LM, Teshome M, Rosso K, Hall C, Song J, et al. The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 10.1245/s10434-020-09392-8
• Survival Analysis of Patients with Inflammatory Breast Cancer in Relation to Clinical and Histopathological Characteristics Cite
  Preda M, Ilina R, Potre O, Potre C, Mazilu O. Survival Analysis of Patients with Inflammatory Breast Cancer in Relation to Clinical and Histopathological Characteristics. Cancer Management and Research. Informa UK Limited; 2020; Volume 12:12447-12455 10.2147/cmar.s278795
• Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery? Cite
  Postlewait LM, Teshome M, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, et al. Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery?. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 27:4603-4612 10.1245/s10434-020-08891-y
• Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database Cite
  Abraham HG, Xia Y, Mukherjee B, Merajver SD. Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 10.1007/s10549-020-05938-2
• The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer Cite
  Grova MM, Strassle PD, Navajas EE, Gallagher KK, Ollila DW, Downs-Canner SM, et al. The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 10.1245/s10434-020-09152-8
• Obesity and related conditions and risk of inflammatory breast cancer: a nested case–control study Cite
  Schairer C, Laurent CA, Moy LM, Gierach GL, Caporaso NE, Pfeiffer RM, et al. Obesity and related conditions and risk of inflammatory breast cancer: a nested case–control study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 183:467-478 10.1007/s10549-020-05785-1
• A large-cohort retrospective study of metastatic patterns and prognostic outcomes between inflammatory and non-inflammatory breast cancer Cite
  Wang Z, Wang H, Ding X, Chen X, Shen K. A large-cohort retrospective study of metastatic patterns and prognostic outcomes between inflammatory and non-inflammatory breast cancer. Therapeutic Advances in Medical Oncology. SAGE Publications; 2020; 12:175883592093267 10.1177/1758835920932674
• Abstract B113: Unique hormone receptor signatures of inflammatory breast cancer in a cohort of Puerto Rican women Cite
  Underill ZC, Rivera M, Martinez MM. Abstract B113: Unique hormone receptor signatures of inflammatory breast cancer in a cohort of Puerto Rican women. Poster Presentations - Proffered Abstracts. American Association for Cancer Research; 2020; 10.1158/1538-7755.disp19-b113
• Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC Cite
  Iwase T, Harano K, Masuda H, Kida K, Hess KR, Wang Y, et al. Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC. BMC Cancer. Springer Science and Business Media LLC; 2020; 20 10.1186/s12885-020-06940-z
• Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana‐Farber Cancer Institute's Inflammatory Breast Cancer Program experience Cite
  Nakhlis F, Regan MM, Chun YS, Dominici LS, Caterson S, Bellon JR, et al. Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana‐Farber Cancer Institute's Inflammatory Breast Cancer Program experience. The Breast Journal. Wiley; 2020; 26:384-390 10.1111/tbj.13509
• Reproductive Risk Factors of Inflammatory Breast Cancer according to Luminal, HER2-Overexpressing, and Triple-Negative Subtypes: A Case Comparison Study Cite
  Mejri N, El Benna H, Rachdi H, Labidi S, Benna M, Daoud N, et al. Reproductive Risk Factors of Inflammatory Breast Cancer according to Luminal, HER2-Overexpressing, and Triple-Negative Subtypes: A Case Comparison Study. Oncology Research and Treatment. S. Karger AG; 2020; 43:204-210 10.1159/000506691
• Changes in steroid hormone profile and tumour progression after genistein treatment of canine inflammatory mammary cancer xenotransplanted mice Cite
  Martín-Ruiz A, Peña L, González-Gil A, Silvan G, Caceres S, Illera J. Changes in steroid hormone profile and tumour progression after genistein treatment of canine inflammatory mammary cancer xenotransplanted mice. Research in Veterinary Science. Elsevier BV; 2020; 131:87-91 10.1016/j.rvsc.2020.04.013
• Abstract P6-15-05: Demographics and survival in metastatic inflammatory breast cancer. SEER data analysis Cite
  Anusim N, Ionescu F, Khoury J, Konde A, Jaiyesimi I. Abstract P6-15-05: Demographics and survival in metastatic inflammatory breast cancer. SEER data analysis. Poster Session Abstracts. American Association for Cancer Research; 2020; 10.1158/1538-7445.sabcs19-p6-15-05
• Radiotherapy after mastectomy has significant survival benefits for inflammatory breast cancer: a SEER population-based retrospective study Cite
  Li Z, Zhang M, Yang Y, Zhou Z, Liu Y, Li H, et al. Radiotherapy after mastectomy has significant survival benefits for inflammatory breast cancer: a SEER population-based retrospective study. PeerJ. PeerJ; 2020; 8:e8512 10.7717/peerj.8512
• Pattern of distant metastases in inflammatory breast cancer - A large-cohort retrospective study Cite
  Wang Z, Chen M, Pan J, Wang X, Chen X, Shen K. Pattern of distant metastases in inflammatory breast cancer - A large-cohort retrospective study. Journal of Cancer. Ivyspring International Publisher; 2020; 11:292-300 10.7150/jca.34572
• Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer Cite
  van Uden DJP, van Maaren MC, Strobbe LJA, Bult P, van der Hoeven JJ, Siesling S, et al. Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer. Breast Cancer Research. Springer Science and Business Media LLC; 2019; 21 10.1186/s13058-019-1201-5
• Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database Cite
  Liu Y, Wang D, Yang Z, Ma R, Li Z, Suo W, et al. Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 178:379-388 10.1007/s10549-019-05385-8
• Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium Cite
  Devi GR, Hough H, Barrett N, Cristofanilli M, Overmoyer B, Spector N, et al. Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium. Journal of Cancer. Ivyspring International Publisher; 2019; 10:3344-3351 10.7150/jca.31176
• Breast cancer histologic subtypes show excess familial clustering Cite
  Henry NL, Cannon‐Albright LA. Breast cancer histologic subtypes show excess familial clustering. Cancer. Wiley; 2019; 125:3131-3138 10.1002/cncr.32198
• Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer Cite
  van Uden DJP, van Maaren MC, Bult P, Strobbe LJA, van der Hoeven JJM, Blanken-Peeters CFJM, et al. Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 176:217-226 10.1007/s10549-019-05219-7
• Low eicosapentaenoic acid and gamma-linolenic acid levels in breast adipose tissue are associated with inflammatory breast cancer Cite
  Chas M, Goupille C, Arbion F, Bougnoux P, Pinault M, Jourdan ML, et al. Low eicosapentaenoic acid and gamma-linolenic acid levels in breast adipose tissue are associated with inflammatory breast cancer. The Breast. Elsevier BV; 2019; 45:113-117 10.1016/j.breast.2019.04.001
• Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program Cite
  Gudina AT, Copeland G, Soliman AS, Hirko KA. Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 173:693-699 10.1007/s10549-018-5037-y
• Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center Cite
  Fouad TM, Ueno NT, Yu RK, Ensor JE, Alvarez RH, Krishnamurthy S, et al. Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center. PLOS ONE. Public Library of Science (PLoS); 2018; 13:e0204372 10.1371/journal.pone.0204372
• Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO) Cite
  Slaoui M, Zoure AA, Mouh FZ, Bensouda Y, El Mzibri M, Bakri Y, et al. Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO). BMC Cancer. Springer Science and Business Media LLC; 2018; 18 10.1186/s12885-018-4634-9
• Effects of indole-3-carbinol on steroid hormone profile and tumor progression in a mice model of canine inflammatory mammarycancer Cite
  Martín-Ruiz A, Peña L, González-Gil A, Díez-Córdova LT, Cáceres S, Illera JC. Effects of indole-3-carbinol on steroid hormone profile and tumor progression in a mice model of canine inflammatory mammarycancer. BMC Cancer. Springer Science and Business Media LLC; 2018; 18 10.1186/s12885-018-4518-z
• The Impact of Locoregional Therapy in Nonmetastatic Inflammatory Breast Cancer: A Population-Based Study Cite
  Muzaffar M, Johnson HM, Vohra NA, Liles D, Wong JH. The Impact of Locoregional Therapy in Nonmetastatic Inflammatory Breast Cancer: A Population-Based Study. International Journal of Breast Cancer. Hindawi Limited; 2018; 2018:1-6 10.1155/2018/6438635
• Development of CNS metastases and survival in patients with inflammatory breast cancer Cite
  Uemura MI, French JT, Hess KR, Liu D, Raghav K, Hortobagyi GN, et al. Development of CNS metastases and survival in patients with inflammatory breast cancer. Cancer. Wiley; 2018; 124:2299-2305 10.1002/cncr.31336
• Factors associated with improved outcomes for metastatic inflammatory breast cancer patients Cite
  Weiss A, Menen RS, Lin HY, Shen Y, Rosso KJ, Shaitelman S, et al. Factors associated with improved outcomes for metastatic inflammatory breast cancer patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 169:615-623 10.1007/s10549-018-4715-0
• BRCAmutations in women with inflammatory breast cancer Cite
  Gutierrez Barrera AM, Fouad TM, Song J, Webster R, Elsayegh N, Wood AL, et al. BRCAmutations in women with inflammatory breast cancer. Cancer. Wiley; 2017; 124:466-474 10.1002/cncr.31069
• Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Cite
  Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:561-564 10.1200/jco.2016.71.0947
• Incidence of inflammatory breast cancer in patients with clinical inflammatory breast symptoms Cite
  Dabi Y, Darrigues L, Pons K, Mabille M, Abd alsamad I, Mitri R, et al. Incidence of inflammatory breast cancer in patients with clinical inflammatory breast symptoms. PLOS ONE. Public Library of Science (PLoS); 2017; 12:e0189385 10.1371/journal.pone.0189385
• Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference Cite
  Woodward WA, Cristofanilli M, Merajver SD, Van Laere S, Pusztai L, Bertucci F, et al. Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference. Journal of Cancer. Ivyspring International Publisher; 2017; 8:3607-3614 10.7150/jca.21200
• Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers Cite
  Monneur A, Goncalves A, Gilabert M, Finetti P, Tarpin C, Zemmour C, et al. Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers. Oncotarget. Impact Journals, LLC; 2017; 8:66019-66032 10.18632/oncotarget.19732
• A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18 Cite
  Chen H, Wu K, Wang M, Wang F, Zhang M, Zhang P. A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18. The Breast. Elsevier BV; 2017; 35:48-54 10.1016/j.breast.2017.06.002
• Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Assessment of Inflammatory Breast Cancer Prior to and After Neoadjuvant Treatment Cite
  van Uden DJ, de Wilt JHW, Meeuwis C, Blanken-Peeters CF, Mann RM. Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Assessment of Inflammatory Breast Cancer Prior to and After Neoadjuvant Treatment. Breast Care. S. Karger AG; 2017; 12:224-229 10.1159/000475745
• Racial and Socioeconomic Disparities Are More Pronounced in Inflammatory Breast Cancer Than Other Breast Cancers Cite
  Denu RA, Hampton JM, Currey A, Anderson RT, Cress RD, Fleming ST, et al. Racial and Socioeconomic Disparities Are More Pronounced in Inflammatory Breast Cancer Than Other Breast Cancers. Journal of Cancer Epidemiology. Hindawi Limited; 2017; 2017:1-8 10.1155/2017/7574946
• Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival Cite
  Stecklein SR, Reddy JP, Wolfe AR, Lopez MS, Fouad TM, Debeb BG, et al. Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival. Journal of Cancer. Ivyspring International Publisher; 2017; 8:1726-1732 10.7150/jca.20095
• Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer Cite
  DeSnyder SM, Mittendorf EA, Le-Petross C, Krishnamurthy S, Whitman GJ, Ueno NT, et al. Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2018; 18:e73-e77 10.1016/j.clbc.2017.06.014
• EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer Cite
  Wang X, Reyes ME, Zhang D, Funakoshi Y, Trape AP, Gong Y, et al. EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer. Oncotarget. Impact Journals, LLC; 2017; 8:67904-67917 10.18632/oncotarget.18958
• The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer Cite
  Nakhlis F, Regan MM, Warren LE, Bellon JR, Hirshfield-Bartek J, Duggan MM, et al. The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2017; 24:2563-2569 10.1245/s10434-017-5903-6
• Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program Cite
  Li J, Xia Y, Wu Q, Zhu S, Chen C, Yang W, et al. Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program. Oncotarget. Impact Journals, LLC; 2017; 8:49370-49379 10.18632/oncotarget.17217
• Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells Cite
  Sauer SJ, Tarpley M, Shah I, Save AV, Lyerly H, Patierno SR, et al. Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells. Carcinogenesis. Oxford University Press (OUP); 2017; 38 10.1093/carcin/bgx003
• Identification of frequent somatic mutations in inflammatory breast cancer Cite
  Matsuda N, Lim B, Wang Y, Krishnamurthy S, Woodward W, Alvarez RH, et al. Identification of frequent somatic mutations in inflammatory breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 163:263-272 10.1007/s10549-017-4165-0
• Inflammatory breast cancer in the Netherlands; improved survival over the last decades Cite
  van Uden DJP, Bretveld R, Siesling S, de Wilt JHW, Blanken-Peeters CFJM. Inflammatory breast cancer in the Netherlands; improved survival over the last decades. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 162:365-374 10.1007/s10549-017-4119-6
• Diabetes, Abnormal Glucose, Dyslipidemia, Hypertension, and Risk of Inflammatory and Other Breast Cancer Cite
  Schairer C, Gadalla SM, Pfeiffer RM, Moore SC, Engels EA. Diabetes, Abnormal Glucose, Dyslipidemia, Hypertension, and Risk of Inflammatory and Other Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2017; 26:862-868 10.1158/1055-9965.epi-16-0647
• Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling Cite
  Allen SG, Chen Y, Madden JM, Fournier CL, Altemus MA, Hiziroglu AB, et al. Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling. Scientific Reports. Springer Science and Business Media LLC; 2016; 6 10.1038/srep39190
• Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database Cite
  Liu J, Chen K, Jiang W, Mao K, Li S, Kim MJ, et al. Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database. Journal of Cancer Research and Clinical Oncology. Springer Science and Business Media LLC; 2016; 143:161-168 10.1007/s00432-016-2281-6
• Disparities in the Use of Postmastectomy Radiation Therapy for Inflammatory Breast Cancer Cite
  Loveland-Jones C, Lin H, Shen Y, Bedrosian I, Shaitelman S, Kuerer H, et al. Disparities in the Use of Postmastectomy Radiation Therapy for Inflammatory Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2016; 95:1218-1225 10.1016/j.ijrobp.2016.02.065
• Importance of hereditary and selected environmental risk factors in the etiology of inflammatory breast cancer: a case-comparison study Cite
  Moslehi R, Freedman E, Zeinomar N, Veneroso C, Levine PH. Importance of hereditary and selected environmental risk factors in the etiology of inflammatory breast cancer: a case-comparison study. BMC Cancer. Springer Science and Business Media LLC; 2016; 16 10.1186/s12885-016-2369-z
• Inflammatory TNBC Breast Cancer: Demography and Clinical Outcome in a Large Cohort of Patients With TNBC Cite
  Biswas T, Efird JT, Prasad S, James SE, Walker PR, Zagar TM. Inflammatory TNBC Breast Cancer: Demography and Clinical Outcome in a Large Cohort of Patients With TNBC. Clinical Breast Cancer. Elsevier BV; 2016; 16:212-216 10.1016/j.clbc.2016.02.004
• Abstract B20: Combination ofGanoderma lucidumextract and erlotinib decreases IBC progression Cite
  Rios-Fuller TJ, Suarez-Arroyo IJ, Lacourt-Ventura M, Maldonado G, Cubano LA, Martinez-Montemayor MM. Abstract B20: Combination ofGanoderma lucidumextract and erlotinib decreases IBC progression. Targeted Therapies. American Association for Cancer Research; 2016; 10.1158/1557-3125.advbc15-b20
• Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression Cite
  Suárez-Arroyo IJ, Rios-Fuller TJ, Feliz-Mosquea YR, Lacourt-Ventura M, Leal-Alviarez DJ, Maldonado-Martinez G, et al. Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression. Journal of Cancer. Ivyspring International Publisher; 2016; 7:500-511 10.7150/jca.13599
• Epidemiological risk factors associated with inflammatory breast cancer subtypes Cite
  Atkinson RL, El-Zein R, Valero V, Lucci A, Bevers TB, Fouad T, et al. Epidemiological risk factors associated with inflammatory breast cancer subtypes. Cancer Causes & Control. Springer Science and Business Media LLC; 2016; 27:359-366 10.1007/s10552-015-0712-3
• Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction Cite
  Raghav K, French JT, Ueno NT, Lei X, Krishnamurthy S, Reuben JM, et al. Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0145534 10.1371/journal.pone.0145534
• Abstract 5548: Reishi reduces the phosphorylation of STAT-3 in inflammatory breast cancerin vitroandin vivomodels Cite
  Martínez-Montemayor MM, Cubano LA, Loperena Y. Abstract 5548: Reishi reduces the phosphorylation of STAT-3 in inflammatory breast cancerin vitroandin vivomodels. Cancer Chemistry. American Association for Cancer Research; 2015; 10.1158/1538-7445.am2015-5548
• Abstract 5556: Enhancing response of Ganoderma lucidum (Reishi) and lapatinib in HER2+ inflammatory breast cancer cells Cite
  Feliz-Mosquea Y, Suarez-Arroyo I, Loperena Y, Cubano LA, Martinez-Montemayor MM. Abstract 5556: Enhancing response of Ganoderma lucidum (Reishi) and lapatinib in HER2+ inflammatory breast cancer cells. Cancer Chemistry. American Association for Cancer Research; 2015; 10.1158/1538-7445.am2015-5556
• Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells Cite
  Cohen EN, Gao H, Anfossi S, Mego M, Reddy NG, Debeb B, et al. Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0132710 10.1371/journal.pone.0132710
• High-Density and Very-Low-Density Lipoprotein Have Opposing Roles in Regulating Tumor-Initiating Cells and Sensitivity to Radiation in Inflammatory Breast Cancer Cite
  Wolfe AR, Atkinson RL, Reddy JP, Debeb BG, Larson R, Li L, et al. High-Density and Very-Low-Density Lipoprotein Have Opposing Roles in Regulating Tumor-Initiating Cells and Sensitivity to Radiation in Inflammatory Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2015; 91:1072-1080 10.1016/j.ijrobp.2014.12.039
• Prevalence of Papillomaviruses, Polyomaviruses, and Herpesviruses in Triple-Negative and Inflammatory Breast Tumors from Algeria Compared with Other Types of Breast Cancer Tumors Cite
  Corbex M, Bouzbid S, Traverse-Glehen A, Aouras H, McKay-Chopin S, Carreira C, et al. Prevalence of Papillomaviruses, Polyomaviruses, and Herpesviruses in Triple-Negative and Inflammatory Breast Tumors from Algeria Compared with Other Types of Breast Cancer Tumors. PLoS ONE. Public Library of Science (PLoS); 2014; 9:e114559 10.1371/journal.pone.0114559
• Abstract 3219: Synergistic effect between Ganoderma lucidum (Reishi) and lapatinib in HER2+ inflammatory breast cancer cells Cite
  Feliz-Mosquea Y, Suárez-Arroyo I, Cubano LA, Martínez-Montemayor MM. Abstract 3219: Synergistic effect between Ganoderma lucidum (Reishi) and lapatinib in HER2+ inflammatory breast cancer cells. Cancer Chemistry. American Association for Cancer Research; 2014; 10.1158/1538-7445.am2014-3219
• Abstract 3673: Role of IL-6 in inflammatory breast cancer and its modulation by Ganoderma lucid (Reishi) Cite
  Loperena-Alvarez Y, Cubano LA, Martínez-Montemayor MM. Abstract 3673: Role of IL-6 in inflammatory breast cancer and its modulation by Ganoderma lucid (Reishi). Immunology. American Association for Cancer Research; 2014; 10.1158/1538-7445.am2014-3673
• Inflammatory Breast Cancer Management in the National Comprehensive Cancer Network: The Disease, Recurrence Pattern, and Outcome Cite
  Matro JM, Li T, Cristofanilli M, Hughes ME, Ottesen RA, Weeks JC, et al. Inflammatory Breast Cancer Management in the National Comprehensive Cancer Network: The Disease, Recurrence Pattern, and Outcome. Clinical Breast Cancer. Elsevier BV; 2015; 15:1-7 10.1016/j.clbc.2014.05.005
• Expression of androgen receptor in inflammatory breast cancer and its clinical relevance Cite
  Gong Y, Wei W, Wu Y, Ueno NT, Huo L. Expression of androgen receptor in inflammatory breast cancer and its clinical relevance. Cancer. Wiley; 2014; 120:1775-1779 10.1002/cncr.28667
• Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort Cite
  Gianni L, Eiermann W, Semiglazov V, Lluch A, Tjulandin S, Zambetti M, et al. Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort. The Lancet Oncology. Elsevier BV; 2014; 15:640-647 10.1016/s1470-2045(14)70080-4
• Survival of women with inflammatory breast cancer: a large population-based study Cite
  Dawood S, Lei X, Dent R, Gupta S, Sirohi B, Cortes J, et al. Survival of women with inflammatory breast cancer: a large population-based study. Annals of Oncology. Elsevier BV; 2014; 25:1143-1151 10.1093/annonc/mdu121
• Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes Cite
  Masuda H, Brewer T, Liu D, Iwamoto T, Shen Y, Hsu L, et al. Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes. Annals of Oncology. Elsevier BV; 2014; 25:384-391 10.1093/annonc/mdt525
• Epigallocatechin-3-Gallate Inhibits Stem-Like Inflammatory Breast Cancer Cells Cite
  Mineva ND, Paulson KE, Naber SP, Yee AS, Sonenshein GE. Epigallocatechin-3-Gallate Inhibits Stem-Like Inflammatory Breast Cancer Cells. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e73464 10.1371/journal.pone.0073464
• Statin use in primary inflammatory breast cancer: a cohort study Cite
  Brewer TM, Masuda H, Liu DD, Shen Y, Liu P, Iwamoto T, et al. Statin use in primary inflammatory breast cancer: a cohort study. British Journal of Cancer. Springer Science and Business Media LLC; 2013; 109:318-324 10.1038/bjc.2013.342
• Anti-Tumor Effects of Ganoderma lucidum (Reishi) in Inflammatory Breast Cancer in In Vivo and In Vitro Models Cite
  Suarez-Arroyo IJ, Rosario-Acevedo R, Aguilar-Perez A, Clemente PL, Cubano LA, Serrano J, et al. Anti-Tumor Effects of Ganoderma lucidum (Reishi) in Inflammatory Breast Cancer in In Vivo and In Vitro Models. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e57431 10.1371/journal.pone.0057431
• Human Cytomegalovirus Infection Enhances NF-κB/p65 Signaling in Inflammatory Breast Cancer Patients Cite
  El-Shinawi M, Mohamed HT, El-Ghonaimy EA, Tantawy M, Younis A, Schneider RJ, et al. Human Cytomegalovirus Infection Enhances NF-κB/p65 Signaling in Inflammatory Breast Cancer Patients. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e55755 10.1371/journal.pone.0055755
• Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines Cite
  Hillyer RL, Sirinvasin P, Joglekar M, Sikes RA, van Golen KL, Nohe A. Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2012; 29:971-979 10.1007/s10585-012-9486-0
• Ganoderma lucidum (Reishi) Inhibits Cancer Cell Growth and Expression of Key Molecules in Inflammatory Breast Cancer Cite
  Martínez-Montemayor MM, Acevedo RR, Otero-Franqui E, Cubano LA, Dharmawardhane SF. Ganoderma lucidum (Reishi) Inhibits Cancer Cell Growth and Expression of Key Molecules in Inflammatory Breast Cancer. Nutrition and Cancer. Informa UK Limited; 2011; 63:1085-1094 10.1080/01635581.2011.601845
• Breast cancer multifocality, disease extent, and survival Cite
  Tot T, Gere M, Pekár G, Tarján M, Hofmeyer S, Hellberg D, et al. Breast cancer multifocality, disease extent, and survival. Human Pathology. Elsevier BV; 2011; 42:1761-1769 10.1016/j.humpath.2011.02.002
• Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer Cite
  Schairer C, Brown LM, Mai PL. Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 129:117-124 10.1007/s10549-010-1324-y
• A cluster of inflammatory breast cancer (IBC) in an office setting: Additional evidence of the importance of environmental factors in IBC etiology Cite
  Levine . A cluster of inflammatory breast cancer (IBC) in an office setting: Additional evidence of the importance of environmental factors in IBC etiology. Oncology Reports. Spandidos Publications; 2010; 24 10.3892/or_00000983
• Human mammary tumor virus in inflammatory breast cancer Cite
  Pogo BG, Holland JF, Levine PH. Human mammary tumor virus in inflammatory breast cancer. Cancer. Wiley; 2010; 116:2741-2744 10.1002/cncr.25179
• Abstract 5583: Innate immune profile of inflammatory breast cancer patients Cite
  Cohen EN, Gao H, Lee B, Andreopoulou E, Jackson SA, Parker CA, et al. Abstract 5583: Innate immune profile of inflammatory breast cancer patients. Clinical Research. American Association for Cancer Research; 2010; 10.1158/1538-7445.am10-5583
• Inflammatory Breast Cancer Survival: The Role of Obesity and Menopausal Status at Diagnosis Cite
  Chang S, Alderfer JR, Asmar L, Buzdar AU. Inflammatory Breast Cancer Survival: The Role of Obesity and Menopausal Status at Diagnosis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2000; 64:157-163 10.1023/a:1006489100283